Related Experiment Video
Updated: Dec 27, 2025

07:32
Assessing Iron Deposition in the Brains of 5xFAD Mice by Perls'/DAB Staining
Published on: May 23, 2025
950
Intracranial iron distribution and quantification in aceruloplasminemia: A case study
Liche Zhou1, Yan Chen2, Yan Li3
1Department of Neurology, Institute of Neurology, Ruijin Hospital affiliated with Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Magnetic Resonance Imaging
|March 2, 2020
Summary
This study quantifies brain iron in Aceruloplasminemia (ACP) using advanced MRI techniques. Findings reveal new iron-overloaded regions, aiding understanding of ACP and related neurodegenerative disorders.
Area of Science:
- Neuroimaging
- Neurodegeneration
- Medical Physics
Background:
- Aceruloplasminemia (ACP) is a rare genetic disorder causing iron accumulation in the brain and body.
- Quantitative assessment of brain iron in ACP patients using MRI has not been extensively performed.
- Understanding brain iron distribution is crucial for ACP pathophysiology and potential treatments.
Purpose of the Study:
- To quantitatively measure iron deposition in specific brain regions of an Aceruloplasminemia patient.
- To explore the relationship between brain iron metabolism and ceruloplasmin function territories.
- To establish a foundation for future quantitative iron measurements in ACP patients.
Main Methods:
- Utilized 3T MRI with a 15-channel head coil for imaging.
- Employed quantitative susceptibility mapping (QSM) and R2* relaxometry for iron quantification.
- Manually segmented gray and white matter regions for analysis.
Main Results:
- Identified significant iron increases in mammillary bodies and lateral habenulae.
- Observed severe iron overload and signal abnormalities in the hippocampus.
- Found strong correlation between R2* and QSM iron measurements (R² = 0.67).
Conclusions:
- QSM and R2* are effective quantitative tools for measuring brain iron.
- The study identified novel brain regions affected by iron overload in ACP.
- Findings may inform iron chelation therapy assessment and research into other iron-related neurodegenerative diseases.

